
    
      Ninetysix children (46 vaccinated, 50 not) with an onset of AOM before six months of age,
      implying a high risk for developing rAOM, were recruited between 2003 and 2007. They were
      closely followed with clinical visits and nasopharyngeal cultures until the age of two years.
    
  